A sharp growth on the way !!!PAVM in Weekly view; regarding the chart's position, and waves, between 35 to 40 percent price growth is expected until the Earning date. Buy is STRONGLY suggested.
−9.20USD
−64.18 MUSD
2.45 MUSD
7.78 M
About PAVmed Inc.
Sector
Industry
CEO
Lishan Aklog
Website
Headquarters
New York
Employees (FY)
107
Founded
2014
FIGI
BBG00DGWP2L8
PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: Medical Devices, Diagnostics, Digital Health, and Emerging Innovations. The company's products include cell collection devices, esophageal DNA tests, carpal tunnel release, implantable intraosseous vascular access devices, and antimicrobial resorbable ear tubes. PAVmed was founded on June 26, 2014 and is headquartered in New York, NY.
PAWM - breaking out?PAWM - the chart looks very strong at this point, breaking out on volume
No major resistance to 14=15 level
PAVM Wayback MachineHad to go way back to find some levels to plot against and 2017 looks like it's the mark. The interesting part is that this 236 area has been an area of traffic in the past. Considering that PAVM failed to break and hold (for now) once again might reinforce that idea. Prior to reaching those highs
$PAVM can rise in the next daysContextual immersion trading strategy idea.
PAVmed Inc . operates as a medical device company in the United States.
The demand for shares of the company looks higher than the supply.
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position again
PAVM: Ascending Triangle (37%), Bullish Pennant (68%)Primary Target (short term):
Ascending Triangle, awaiting confirmation (37%)
PT = 6.85$
Secondary Target (Long term):
Bullish Pennant (68%)
PT = 8.40$
$PAVM can rise in the next daysContextual immersion trading strategy idea.
PAVmed Inc. operates as a medical device company in the United States.
The demand for shares of the company looks higher than the supply.
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position from
$PAVM ABCD/Lightning 618% Demand $PAVM , Looking for bullish price action (pin bar, engulfing candle, inside bar) at demand zone highlighted. There is value here imo, i have a ton off DD on this, drop me a message, ill be happy to share it, thanks for looking.
PAVM: Bullish PennantBullish Pennant
Pros:
Descending volume during formation
Golden cross in blue
PPS above 50MA and 200MA
RS above 0, and ascending
ATR Ascending
R/R ratio above 7
250RSI above 50
Cons:
200MA flat
Target:
PT = 7.74$
Thank you to those who donate Coins!
Stay Humble, have fun, make money!
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PAVM is 1.87 USD — it has decreased by 0.53% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange PAVmed Inc. stocks are traded under the ticker PAVM.
PAVmed Inc. is going to release the next earnings report on May 22, 2024. Keep track of upcoming events with our Earnings Calendar.
PAVM stock is 5.46% volatile and has beta coefficient of 2.10. Check out the list of the most volatile stocks — is PAVmed Inc. there?
PAVM earnings for the last quarter are −2.07 USD per share, whereas the estimation was −1.77 USD resulting in a −17.07% surprise. The estimated earnings for the next quarter are −1.63 USD per share. See more details about PAVmed Inc. earnings.
PAVmed Inc. revenue for the last quarter amounts to 791.00 K USD despite the estimated figure of 658.00 K USD. In the next quarter revenue is expected to reach 1.05 M USD.
Yes, you can track PAVmed Inc. financials in yearly and quarterly reports right on TradingView.
PAVM stock has fallen by 6.03% compared to the previous week, the month change is a 15.38% fall, over the last year PAVmed Inc. has showed a 76.07% decrease.
PAVM net income for the last quarter is −14.04 M USD, while the quarter before that showed −17.67 M USD of net income which accounts for 20.57% change. Track more PAVmed Inc. financial stats to get the full picture.
Today PAVmed Inc. has the market capitalization of 17.24 M, it has decreased by 7.59% over the last week.
No, PAVM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PAVM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PAVmed Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 107.00 employees. See our rating of the largest employees — is PAVmed Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PAVmed Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PAVmed Inc. stock shows the sell signal. See more of PAVmed Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on PAVmed Inc. future price: according to them, PAVM price has a max estimate of 26.00 USD and a min estimate of 4.00 USD. Read a more detailed PAVmed Inc. forecast: see what analysts think of PAVmed Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PAVmed Inc. EBITDA is −65.67 M USD, and current EBITDA margin is −2.69 K%. See more stats in PAVmed Inc. financial statements.